tirzepatide blindness risk Does Cause Photosensitivity? FDA Label Facts Does GLP-1 Cause Eye Problems?

I thought about asking the doctor or nurse next time I saw them for their logic (but in todays environment the standard answer from them is if you ask questions, they consider that aggressive behaviour, so Ive been rather put off speaking up)

Some patients may have a higher risk of developing Mounjaro eye problems, including: Individuals with existing diabetic retinopathy, who may notice Mounjaro blurry vision or vision changes

Zepbound and Mounjaro are dual-agonist drugs and activate two receptors in the brain and throughout the body: GLP-1 and glucose-dependent insulinotropic polypeptide or GIP

Aside from C1QBP, insulin/IGF-1 can also alter the nuclear factor-kB (NF-kB) signal pathway, Polo-like kinase 1 (PLK1), NADPH oxidase 4 (NOX4), and mammalian target of rapamycin (mTOR) to reverse apoptosis, repair DNA and induce multi-drug resistance gene (Lee et al., 2007

At first, Wegovy was FDA-approved for chronic weight management when paired with exercise, dietary modifications, and increased physical activity in patients with obesity (body mass index 30 kg/m or more) and overweight (BMI 27 kg/m or more) with at least one weight-related health condition such as heart diseases, high blood pressure (hypertension), high cholesterol levels, type 2 diabetes, and sleep apnea